Menter A, Boh E, Lewitt G, Jacobson A. Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2024 Jul. 3];5(6):s51. Available from: https://jofskin.org/33014/index.php/skin/article/view/1402